Fundamentals to Applications: The Practical Luminescence Lanthanide Toolbox for Imaging of Key Cell Cycle Regulators (Plk1) and Inhibition of Tumor Cells

Keyphrases

1. Polo-like Kinase 1 (PLK1) 100%
2. Lysosome 71%
3. Tumor Cells 57%
4. Upconversion Nanocrystals 57%
5. Specific Peptide 53%
6. Water-soluble 47%
7. Small Molecules 44%
8. Chromophore 34%
9. NaGdF4 32%
10. Europium Complex 31%
11. In Vivo Imaging 31%
12. Biological Applications 31%
13. Cell Cycle Regulators 28%
14. Cell Cycle Inhibitors 28%
15. G2 Phase 28%
16. Linker Length 28%
17. Luminescence 28%
18. Key Cells 28%
19. Infected Tumor 28%
20. EBNA1 28%
21. Gallium Porphyrin 28%
22. Functionalized Porphyrin 28%
23. SILAC 28%
24. Lanthanide Upconversion 28%
25. Lanthanides 28%
26. Disubstituted 28%
27. Polyamines 28%
28. Bioprobe 28%
29. Amphiphilic Porphyrins 28%
30. Antenna 28%
31. Oxidative Stress 28%
32. Induced Oxidative Stress 28%
33. Antitumor Effect 28%
34. Amphiphilic 28%
35. Prostate Cancer Screening 28%
36. Human Ovarian Cancer 28%
37. Tumor Suppressor 28%
38. Fast Response 28%
39. Photosensitization 28%
40. Prostate Cancer 28%
41. Quantitative Proteomics 28%
42. Photodynamic Therapy Agents 28%
43. Cyclen 28%
44. Benign Prostatic Hyperplasia 21%
45. Spermine 21%
46. Nanoparticles 21%
47. Cancer Cells 17%
48. Cellular Uptake 17%
49. Time-resolved 17%
50. Shape Effect 14%
51. Microwave Methodology 14%
52. Cell Cycle Inhibition 14%
53. Total Prostate-specific Antigen 14%
54. Prostate-specific Antigen Testing 14%
55. In Vitro Biological Studies 14%
56. Labeling Probes 14%
57. Emission Spectrum 14%
58. Room Temperature 14%
59. Ethynyl 14%
60. Biolabeling 14%
61. Hybrid Nanomaterials 14%
62. Dysregulated 14%
63. Photophysical 14%
64. Sequence Pattern 14%
65. Subcellular Localization 14%
66. Eu3+ 14%
67. Cellular Uptake Efficiency 14%
68. Titration 14%
69. Inhibitory Effect 14%
70. Pyridine 14%
71. Cell Arrest 14%
72. Metallic Ratio 14%
73. Cytotoxicity Assay 14%
74. Chelates 14%
75. Silica 14%
76. Structural Characterization 14%
77. Photophysical Properties 14%
78. Optical Imaging 14%
79. Stability Testing 14%
80. Bimetallic 14%
81. Short Reaction Time 14%
82. Positron Emission Tomography 14%
83. 4-methyl-2 14%
84. Low Temperature 14%
85. Photodynamic Therapy 14%
86. BaGdF5 10%
87. Lanthanide Complexes 9%
88. Dimerization Inhibitors 9%
89. Binder 9%
90. Small Molecule Inhibitors 7%
91. Cell Permeable 7%
92. Patient-controlled 7%
93. Primary Screening 7%
94. Secondary Screening 7%
95. Gray Zone 7%
96. Prostatic Biopsy 7%
97. Acid Hydrolase 7%
98. TCIRG1 7%
99. Transrectal Ultrasound 7%
100. Prostate Cancer Biomarker 7%
101. Response Mechanism 7%
102. Phosphorylation Sites 7%
103. Spermidine 7%
104. Ultra-high Performance Liquid Chromatography (UHPLC) 7%
105. Diagnostic Accuracy 7%
106. Diagnostic Biomarker 7%
107. Cellular Mechanisms 7%
108. Protein Oxidation 7%
109. Virus Invasion 7%
110. Triple Quadrupole Mass Spectrometer 7%
111. Biological Systems 7%
112. Cellular Response 7%
113. Methionine 7%
114. High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS) 7%
115. Phosphorylation 7%
116. Prostate Cancer Patients 7%
117. Urinary Levels 7%
118. Diagnostic Performance 7%
119. Receiver Operating Characteristic Curve 7%
120. Phosphoprotein 7%
121. Student's T-test 7%
122. Environmental Pressure 7%
123. Irradiation 7%
124. Healthy Controls 7%
125. Proton Pump 7%
126. Area under the Curve 7%
127. Neurodegenerative Diseases 7%
128. Prostate-specific Antigen 7%
129. Screening Method 7%
130. Parkinson's Disease 7%
131. Gadolinium-based 7%
132. Biogenic Polyamines 7%
133. Putrescine 7%
134. Redox Regulation 7%
135. New Targets 7%
136. Singlet Oxygen 7%
137. Er3+ 7%
138. Proteomic Analysis 7%
139. Yb3+ 7%
140. Urine Samples 7%
141. Oxidized Proteins 7%
142. Mitosis 6%
143. Microtubules 6%